STAT

Opinion: Faster concussion diagnoses are on the horizon. Patent filings offer a peek

Companies trying to develop new ways to diagnose a concussion aim to meet the same design requirements — fast, accessible, and objective tests that can be deployed immediately where the…
Companies are exploring a variety of ways to more rapidly diagnose the 3.8 million concussions that occur each year as a result of sports and recreational activities.

Exactly what repeated concussions do to the brain is a hotly debated question at the forefront of national discussion. The billion-dollar settlement with the National Football League and landmark studies about the prevalence of a serious form of brain damage known as chronic traumatic encephalopathy among NFL athletes have alarmed many that the demise of American football — all the way from the professional level to youth sports — may be on the horizon.

In the United States, an estimated occur each year during competitive sports and recreational activities. It is difficult, if not impossible, to accurately diagnose these injuries immediately after they occur. Rapid detection is important because an athlete suspected of having a concussion should immediately stop playing, seek medical attention, and rest until symptoms subside completely.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks